ADIL - Financial Reports List - Adial Pharmaceuticals, Inc. - IntrinsicAlpha

Adial Pharmaceuticals, Inc. ADIL

Healthcare - Biotechnology - NASDAQ - US

$ 0.719

-2.02 %

$ 5.68 M

Market Cap

-0.82

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q1	8-K	2025-03-31	0.00%	65.59%	-22.89%
Quarterly Report	Q4	8-K	2024-12-31	0.00%	-7.83%	-8.80%
Annual Report	FY	10-K	2024-12-31	0.00%	-88.48%	-20.27%
Quarterly Report	Q3	8-K	2024-09-30	0.00%	-58.26%	-62.86%
Quarterly Report	Q2	8-K	2024-06-30	0.00%	-225.99%	-54.82%
Quarterly Report	Q1	8-K	2024-03-31	0.00%	-124.03%	36.83%
Quarterly Report	Q4	8-K	2023-12-31	0.00%	33.01%	44.94%
Annual Report	FY	10-K	2023-12-31	0.00%	45.00%	48.28%
Quarterly Report	Q3	8-K	2023-09-30	0.00%	54.31%	57.40%
Quarterly Report	Q2	8-K	2023-06-30	0.00%	128.15%	61.43%

1